388 related articles for article (PubMed ID: 18618353)
1. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
2. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
3. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
[TBL] [Abstract][Full Text] [Related]
4. Lack of depression effect on platelet activation in patients with heart failure.
Pasic J; Sullivan MD; Russo J; Chandler WL; Levy WC
Psychiatry Res; 2004 Dec; 129(3):289-92. PubMed ID: 15661323
[TBL] [Abstract][Full Text] [Related]
5. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
6. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
7. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
8. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Lim HS; Blann AD; Lip GY
Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
[TBL] [Abstract][Full Text] [Related]
10. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
[TBL] [Abstract][Full Text] [Related]
11. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan JS; Lip GY; Bareford D; Blann AD
Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
[TBL] [Abstract][Full Text] [Related]
12. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
[TBL] [Abstract][Full Text] [Related]
13. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
[TBL] [Abstract][Full Text] [Related]
14. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Purdy G; Lawrie AS; Watt H; Brown MM; Machin SJ
Br J Haematol; 2004 Jun; 125(6):777-87. PubMed ID: 15180868
[TBL] [Abstract][Full Text] [Related]
15. Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia.
Leinoe EB; Hoffmann MH; Kjaersgaard E; Johnsen HE
Br J Haematol; 2004 Oct; 127(1):76-84. PubMed ID: 15384980
[TBL] [Abstract][Full Text] [Related]
16. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer.
Mantur M; Kemona H; Kozłowski R; Kemona-Chetnik I
Neoplasma; 2003; 50(4):262-5. PubMed ID: 12937838
[TBL] [Abstract][Full Text] [Related]
17. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
[TBL] [Abstract][Full Text] [Related]
18. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure.
O'Connor CM; Gurbel PA; Serebruany VL
Am J Cardiol; 1999 May; 83(9):1345-9. PubMed ID: 10235093
[TBL] [Abstract][Full Text] [Related]
20. Development of a whole platelet ELISA to detect circulating activated platelets.
Amrani DL; Stojanovic L; Mosesson MN; Shalev Y; Mosesson MW
J Lab Clin Med; 1995 Dec; 126(6):603-11. PubMed ID: 7490520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
